Bivalirudin overdose: Difference between revisions

Jump to navigation Jump to search
m (Protected "Bivalirudin overdose" [edit=sysop:move=sysop])
 
No edit summary
Line 1: Line 1:
{{CMG}}
Adverse reactions have not been reported; however, monitor for signs of bleeding.
Adverse reactions have not been reported; however, monitor for signs of bleeding.
{{FDA}}

Revision as of 14:41, 9 February 2009

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Adverse reactions have not been reported; however, monitor for signs of bleeding.



Adapted from the FDA Package Insert.